drugset / Trial / NCT02261376

Effects of Age, Gender & Race on the Pharmacokinetics (PK)of DS-1971a

NCT02261376

Phase 1 Completed 48 enrolled Daiichi Sankyo
Non-randomizedParallel-groupOpen-labelBasic science

Summary

This is an open label, non-randomised, single-dose, parallel-group study in 48 healthy subjects enrolled in 4 cohorts - Caucasian men, aged 18-55 years, Caucasian men, aged 65 years or older, Japanese men, aged 18-55 years, Caucasian women, aged 18-55 years.

Timeline

Start
2014-09
Primary completion
2014-11
Completion
2014-11

Drugs

EvaluationDrugModalityDoseRoute
Subject DS-1971 Small molecule 200 mg Oral

Indications

No indication recorded.